RG
Regenicin, Inc.
RGIN · OTC
$0.00 +0.00% (+$0.00)
Market Cap $15.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
38 /100
Average ROA 4,124.18%
Asset turnover 0.00x
ROIC 12.13%
Debt
50 /100
Moderate Int. coverage -16.63x
Net debt/EBITDA -1.05x
Current ratio 0.00x
Stability
58 /100
Moderate EPS volatility 18.56%
Profitable years 0
Beta -2.27x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na RGIN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Randall E. McCoy
Employees
3
Headquarters
Little Falls